Cilostazol 71610-0813-26
- Manufacturer
- Aphena Pharma Solutions - Tennessee, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 12, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA077030
Need to source Cilostazol? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cilostazol | 100 mg/1 |
Drug Class
Phosphodiesterase 3 Inhibitor [EPC]Phosphodiesterase 3 Inhibitor [EPC]Phosphodiesterase 3 Inhibitors [MoA]
Selected Package
71610-0813-26Selected1200 TABLET in 1 BOTTLE (71610-813-26)